A trial of a permanent prostatic urethral stent for treatment of BPH demonstrated early success. A novel prostatic urethral stent can reduce lower urinary tract symptoms (LUTS) in men with benign ...

SRS Medical has announced it has acquired a prostatic stent from AbbeyMoor Medical, according to a news release. The Spanner temporary prostatic stent is only FDA-cleared temporary stent for the male ...

DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...

In a trial, the newly approval urethral stent provided significant and durable relief of BPH-related LUTS over 12 months. The FDA has approved the ProVee® System for treatment of benign prostatic ...

ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stentlike implant to relieve the urinary symptoms of an enlarged prostate. Known as ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

The MarketWatch News Department was not involved in the creation of this content. DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and ...